USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
VITACYTE, LLC
Address:
1102 INDIANA AVE
INDIANAPOLIS, IN 46202-5130
Phone:
N/A
URL:
N/A
EIN:
470930763
DUNS:
141020979
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,276,346.00 4
SBIR Phase II $1,715,218.00 1

Award List:

Tissue Dissociation Enzymes for Islets & Other Cells

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$572,658.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Tissue dissociation enzyme (TDE) products have not been improved for over 50 years. "Crude collagenase" products contain collagenases and other proteases used to free cells from collagen rich, extracellular matrix. They are derived from minimally purified… More

System to analyze factors affecting human islet yield

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$195,331.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The Edmonton Protocol is a breakthrough in the treatment of adult, type 1 diabetic patients and heralds a new era in transplantation medicine. Edmonton's success rate, as measured by insulin independence > 1 year post transplant, is comparable to whole organ… More

Improved recombinant collagenase for tissue dissociation

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$276,028.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The quality of tissue dissociation enzymes (TDEs) containing collagenase was critical to the success of the Edmonton Protocol, an islet transplantation procedure that led to successful treatment of adult type 1 diabetic patients who were disabled by refractory… More

Tissue Dissociation Enzymes for Islets and Other Cells

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$1,715,218.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): VitaCyte LLC is working to improve tissue dissociation enzymes (TDE) required for the isolation of insulin producing pancreatic islet cells from both human and porcine organs. Transplantation of islets into Type 1 Diabe tic patients represents a promising therapy… More

Digital image analysis for quantitative and qualitative assessment of pig islets

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$232,329.00
Agency:
HHS
Principal Investigator:
Michael L. Green – 317-917-3457
Abstract:
DESCRIPTION (provided by applicant): The demonstration by the Edmonton group that human islet transplantation can be successfully used to manage adult type 1 diabetes patients with refractory hypoglycemia has led to increased funding of clinical trials andfurther research to extend the scope of this… More